Tardive Oculogyric Crisis Due to Aripiprazole Treatment in an Adolescent Patient Diagnosed with Bipolar Disorder

Simple item page
dc.contributor.authorCanol T.
dc.contributor.authorSapmaz S.Y.
dc.contributor.authorUzun A.D.
dc.contributor.authorKandemir H.
dc.date.accessioned2025-04-10T11:06:21Z
dc.date.available2025-04-10T11:06:21Z
dc.date.issued2020
dc.description.abstractAntipsychotics usage in children and adolescents is becoming widespread. One of the extrapyramidal side effects associated with long-term antipsychotic drug use follow-up is an oculogyric crisis (OGC). OGC is defined as a dystonic reaction commonly observed after typical antipsychotic drug administration. However, there are rare cases which report OGC after atypical antipsychotic use. In this report, we present an adolescent with bipolar disorder who developed OGC after 2 years of aripiprazole and quetiapine use. To best of our knowledge, this case report has been the first case to present the clinical presentation of tardive OGC due to aripiprazole treatment in an adolescent patient. It is important to note that OGC might be observed in the acute phase and it might be as a result of chronic use detected during a clinical follow-up. Safety, tolerability and efficiency of aripiprazole in pediatric populations should be further analyzed in the future studies. © 2020, AVES. All rights reserved.
dc.identifier.DOI-ID10.5455/PCP.20200522115147
dc.identifier.urihttp://hdl.handle.net/20.500.14701/46648
dc.publisherAVES
dc.titleTardive Oculogyric Crisis Due to Aripiprazole Treatment in an Adolescent Patient Diagnosed with Bipolar Disorder
dc.typeArticle

Files

Collections

Scopus Koleksiyonu